2. Academic Validation
  3. Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells

Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells

  • Drug Des Devel Ther. 2019 Jul 2;13:2135-2144. doi: 10.2147/DDDT.S199459.
Kang Wang  # 1,  Zhengyang Zhang  # 1,  Ming Wang 1,  Xiongfeng Cao 1,  Jianchen Qi 1,  Dongqing Wang 1 2,  Aihua Gong 3,  Haitao Zhu 1 2
Affiliations

Affiliations

  • 1 Central Laboratory of Medical Imaging, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, People's Republic of China.
  • 2 Department of Radiology, Affiliated Hospital of Jiangsu University, Zhenjiang 212001, People's Republic of China.
  • 3 School of Medicine, Jiangsu University, Zhenjiang 212013, People's Republic of China.
  • # Contributed equally.
PMID: 31456633 DOI: 10.2147/DDDT.S199459
Abstract

Objective: To investigate the exact role of GRP78 in artesunate-induced Ferroptosis in KRAS mutant pancreatic Cancer cells. Methods: Artesunate-induced KRAS mutant human pancreatic Cancer cells (AsPC-1 and PaTU8988) Ferroptosis was confirmed by fluorescent staining experiments and CCK8. Western blot and short-hairpin RNA-based knockdown assays were conducted to detect GRP78 activity and its role in artesunate-induced Ferroptosis. Results: Artesunate induced AsPC-1 and PaTU8988 cell death in Ferroptosis manner, rather than necrosis or Apoptosis. In addition, artesunate increased the mRNA and protein levels of GRP78 in a concentration-dependent manner in AsPC-1 and PaTU8988 cells. Knockdown GRP78 enhanced artesunate-induced Ferroptosis of pancreatic Cancer cells in vitro and in vivo. Conclusion: Combining artesunate with GRP78 inhibition may be a novel maneuver for effective killing of KRAS mutant pancreatic ductal adenocarcinoma cells.

Keywords

GRP78; artesunate; ferroptosis; pancreatic cancer.

Figures
Products